0

524506

CORALAB

img img img img
No Data Available

CORAL LABORATORIES LTD. Share Price Update

As of the latest trading session, CORAL LABORATORIES LTD. share price is currently at ₹428.6, which is up by ₹1.14 from its previous closing. Today, the stock has fluctuated between ₹422.00 and ₹436.45. Over the past year, CORAL LABORATORIES LTD. has achieved a return of -45.96%. In the last month alone, the return has been -1.85%.

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

CORAL LABORATORIES LTD. fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    153.00

  • P/E Ratio (TTM)

    10.91

  • Beta

    0.60

  • Book Value / share

    596.88

  • Return on equity

    12.76%

  • EPS (TTM)

    40.01

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    2.78

info icon alternate text

CORAL LABORATORIES LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2025 (Values in Cr)
Revenue 21.56
Operating Expense 20.36
Net Profit 2.78
Net Profit Margin (%) 12.89
Earnings Per Share (EPS) 7.77
EBITDA 4.39
Effective Tax Rate (%) 24.86
Particulars SEP 2025 (Values in Cr)
Revenue 19.03
Operating Expense 14.65
Net Profit 5.82
Net Profit Margin (%) 30.58
Earnings Per Share (EPS) 16.29
EBITDA 7.97
Effective Tax Rate (%) 21.56
Particulars JUN 2025 (Values in Cr)
Revenue 18.82
Operating Expense 17.15
Net Profit 2.56
Net Profit Margin (%) 13.60
Earnings Per Share (EPS) 7.18
EBITDA 4.23
Effective Tax Rate (%) 31.18
Particulars MAR 2025 (Values in Cr)
Revenue 28.13
Operating Expense 26.00
Net Profit 2.83
Net Profit Margin (%) 10.06
Earnings Per Share (EPS) 7.91
EBITDA 4.40
Effective Tax Rate (%) 26.49
Particulars DEC 2024 (Values in Cr)
Revenue 22.99
Operating Expense 17.20
Net Profit 6.14
Net Profit Margin (%) 26.70
Earnings Per Share (EPS) 17.20
EBITDA 8.83
Effective Tax Rate (%) 26.11
Particulars MAR 2025 (Values in Cr)
Revenue 115.01
Operating Expense 90.88
Net Profit 24.16
Net Profit Margin (%) 21.00
Earnings Per Share (EPS) 67.61
EBITDA 34.58
Effective Tax Rate (%) 25.59
Particulars MAR 2024 (Values in Cr)
Revenue 83.66
Operating Expense 69.40
Net Profit 15.79
Net Profit Margin (%) 18.87
Earnings Per Share (EPS) 44.19
EBITDA 22.71
Effective Tax Rate (%) 23.83
Particulars MAR 2023 (Values in Cr)
Revenue 78.12
Operating Expense 76.83
Net Profit 6.45
Net Profit Margin (%) 8.25
Earnings Per Share (EPS) 18.04
EBITDA 10.75
Effective Tax Rate (%) 21.62
Particulars MAR 2022 (Values in Cr)
Revenue 75.61
Operating Expense 69.53
Net Profit 9.05
Net Profit Margin (%) 11.96
Earnings Per Share (EPS) 25.32
EBITDA 13.99
Effective Tax Rate (%) 23.69
Particulars MAR 2021 (Values in Cr)
Revenue 96.57
Operating Expense 82.74
Net Profit 13.55
Net Profit Margin (%) 14.03
Earnings Per Share (EPS) 37.94
EBITDA 19.63
Effective Tax Rate (%) 23.05
Particulars MAR 2025 (Values in Cr)
Book Value / Share 563.19
ROE % 12.76
ROCE % 16.98
Total Debt to Total Equity 0.01
EBITDA Margin 30.07
Particulars MAR 2024 (Values in Cr)
Book Value / Share 496.83
ROE % 9.50
ROCE % 12.26
Total Debt to Total Equity 0.00
EBITDA Margin 27.15
Particulars MAR 2023 (Values in Cr)
Book Value / Share 433.29
ROE % 4.15
ROCE % 5.23
Total Debt to Total Equity 0.02
EBITDA Margin 13.76
Particulars MAR 2022 (Values in Cr)
Book Value / Share 436.81
ROE % 6.18
ROCE % 7.70
Total Debt to Total Equity 0.04
EBITDA Margin 18.50
Particulars MAR 2021 (Values in Cr)
Book Value / Share 382.48
ROE % 10.74
ROCE % 13.28
Total Debt to Total Equity 0.05
EBITDA Margin 20.34
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 79.86
Total Assets 229.46
Total Liabilities 229.46
Total Equity 201.20
Share Outstanding 0
Price to Book Ratio 1.25
Return on Assets (%) 10.52
Return on Capital (%) 11.8
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 61.28
Total Assets 205.68
Total Liabilities 205.68
Total Equity 177.49
Share Outstanding 0
Price to Book Ratio 0.75
Return on Assets (%) 7.67
Return on Capital (%) 8.9
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 40.40
Total Assets 174.34
Total Liabilities 174.34
Total Equity 154.79
Share Outstanding 0
Price to Book Ratio 0.53
Return on Assets (%) 3.69
Return on Capital (%) 4.16
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 37.47
Total Assets 189.89
Total Liabilities 189.89
Total Equity 156.05
Share Outstanding 0
Price to Book Ratio 0.58
Return on Assets (%) 4.76
Return on Capital (%) 5.58
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 34.82
Total Assets 167.53
Total Liabilities 167.53
Total Equity 136.64
Share Outstanding 0
Price to Book Ratio 0.84
Return on Assets (%) 8.09
Return on Capital (%) 9.49
Particulars MAR 2025 (Values in Cr)
Net Income 33.23
Cash from Operations 6.10
Cash from Investing -0.15
Cash from Financing 2.70
Net change in Cash 1.33
Free Cash Flow 6.57
Particulars MAR 2024 (Values in Cr)
Net Income 20.89
Cash from Operations -0.57
Cash from Investing 1.39
Cash from Financing 0.00
Net change in Cash -4.05
Free Cash Flow 0.41
Particulars MAR 2023 (Values in Cr)
Net Income 8.18
Cash from Operations 14.63
Cash from Investing -2.61
Cash from Financing -6.42
Net change in Cash 3.62
Free Cash Flow 16.57
Particulars MAR 2022 (Values in Cr)
Net Income 10.89
Cash from Operations 10.45
Cash from Investing -6.05
Cash from Financing 0.14
Net change in Cash 0.18
Free Cash Flow 16.00
Particulars MAR 2021 (Values in Cr)
Net Income 17.59
Cash from Operations 4.35
Cash from Investing -0.06
Cash from Financing 0.35
Net change in Cash 1.21
Free Cash Flow 5.71
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 26.10 11.30 1.35 200.01 23.12 / 43.30
BLISS GVS PHARMA LTD 225.00 21.51 2.10 2380.25 105.05 / 244.05
CIPLA LTD 1326.10 22.53 3.25 107119.80 1283.00 / 1672.20
FERMENTA BIOTECH LIMITED 335.15 11.15 2.52 986.38 219.00 / 399.00
GLAXOSMITHKLINE PHARMA LT 2637.35 44.42 26.16 44678.30 2220.00 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 26.10 25.10 3.63 200.01 23.12 / 43.30
AMRUTAJAN HEALTH LTD 602.95 30.15 5.09 1743.17 548.05 / 789.95
ASTRAZENECA PHARMA IND LT 8871.90 106.62 27.75 22179.75 6501.60 / 10653.05
BLISS GVS PHARMA LTD 225.00 30.65 2.15 2380.25 105.05 / 244.05

CORAL LABORATORIES LTD. shareholding pattern

Holding

28.48%
71.51%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

CORAL LABORATORIES LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
428.60 0.26 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 434.80
  • 26 Days 448.70
  • 10 Days 442.70
  • 50 Days 454.90
  • 12 Days 444.40
  • 100 Days 476.30
  • 20 Days 447.50
  • 200 Days 521.20
428.45 PIVOT

First Support

419.10

First Resistance

436.80

Second Support

410.75

Second Resistance

446.15

Third Support

401.40

Third Resistance

454.50

RSI

41.81

ADX

18.48

MACD

-4.30

Williams % R

-90.32

Commodity Channel Index (CCI)

-102.09

Date

2026-02-23

Week

2134.00

Same Day

811.00

Month

2517.00

1 Year

0.60

3 Year

0.83

Over 1 Month

-1.85%

down

Over 1 Year

-45.96%

down

Over 3 Months

-13.99%

down

Over 3 Years

18.35%

down

Over 6 Months

-9.49%

down

Over 5 Years

3.15%

down

CORAL LABORATORIES LTD. Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
19 Sep 2025 1.5 Final 19 Sep 2025 Equity shares
20 Sep 2024 2.0 Final 21 Sep 2024 Equity shares
19 Sep 2019 2.0 Final 21 Sep 2019 Equity shares
18 Sep 2018 2.0 Final 21 Sep 2018 Equity shares
11 Sep 2017 5.0 Final 13 Sep 2017 Equity shares
16 Sep 2016 3.0 Final 20 Sep 2016 Equity shares
08 Sep 2015 2.5 Final 10 Sep 2015 Equity shares
16 Sep 2014 2.0 Final 18 Sep 2014 Equity shares
18 Sep 2013 1.5 Final 20 Sep 2013 Equity shares
17 Sep 2012 1.5 Final 19 Sep 2012 Equity shares
19 Sep 2011 1.5 Final 21 Sep 2011 Equity shares
17 Sep 2010 1.5 Final 21 Sep 2010 Equity shares
17 Sep 2009 1.2 Final 22 Sep 2009 Equity shares
19 Sep 2008 1.0 Final 23 Sep 2008 Equity shares
20 Sep 2007 1.5 Final 24 Sep 2007 Equity shares
20 Sep 2005 0.0 Final 22 Sep 2005 Equity shares

Top Gainers

CORAL LABORATORIES LTD. Share Price

Coral Laboratories Limited (CLL) was established in February, 1997. It was promoted by Navin B Doshi of the DWD Group. To manufacture pharmaceutical formulations like tablets, capsules, liquid and topical preparation, the Company came up with a public issue in March, 1994 by raising funds of Rs.2.5 Crore. It setup an additional ultra-modern manufacturing unit at Daman and the said Unit started the commercial production during March 2004. It started the commercial production at Dehradun Plant in September, 2006.

Presently, Company is into manufacturing of Generic Branded, Nutraceuticals, OTC and Herbal Medicines. It produces various pharmaceutical formulations in 3 different locations all over India. It has plants at Daman and Dehradun .

Parent organization Coral
NSE symbol [-]
Founded 1981
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Coral Laboratories Ltd?

Answer Field

Coral Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 428.60 as on Feb 24 2026 03:29 PM.

What is the Market Cap of Coral Laboratories Ltd Share?

Answer Field

The market cap of Coral Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 153.00 as on Feb 24 2026 03:29 PM.

What is the 52 Week High and Low of Coral Laboratories Ltd?

Answer Field

The 52 Week High and Low of Coral Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 805.00 and ₹ 415.00.

What is 1 year return for Coral Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been -45.96%.

What is the P/E Ratio of Coral Laboratories Ltd Share?

Answer Field

As on Feb 24 2026 03:29 PM the price-to-earnings (PE) ratio for Coral Laboratories Ltd share is 10.91.

What is the PB ratio of Coral Laboratories Ltd Share?

Answer Field

As on Feb 24 2026 03:29 PM, the price-to-book (PB) ratio for Coral Laboratories Ltd share is 596.88.

How to Buy Coral Laboratories Ltd Share?

Answer Field

You can trade in Coral Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Coral Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Coral Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Coral Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59